Significantly, dysregulated CB2 tone, characterized by reduced receptor activity, increased eCBs catabolism, and heightened cytokine release, has been documented in atopic dermatitis, psoriasis, acne, and chronic wounds. This evidence concerns the gene CNR2 and atopic eczema.